Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Prevention Research

• Publication date

  2015-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-15-0130PMID 26130253PMCID PMC4560605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network

  2016cited by this paper
• Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

  2015cited by this paper
• Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

  2014influential reference
• Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention

  2014cited by this paper
• Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

  2014cited by this paper
• Genome‐wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis

  2014cited by this paper
• Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

  2014cited by this paper
• Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis

  2014influential reference
• Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations

  2014cited by this paper
• Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

  2014cited by this paper
• Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity

  2013influential reference
• A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus

  2013cited by this paper
• A model to determine absolute risk for esophageal adenocarcinoma.

  2013cited by this paper
• Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.

  2013cited by this paper
• Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus

  2013influential reference
• Punctuated evolution of prostate cancer genomes.

  2013cited by this paper
• Emerging landscape of oncogenic signatures across human cancers

  2013cited by this paper
• Pan-cancer patterns of somatic copy-number alteration

  2013cited by this paper
• Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

  2012cited by this paper
• Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

  2012influential reference
• Abstract 4383: Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma

  2012cited by this paper
• Absolute quantification of somatic DNA alterations in human cancer

  2012cited by this paper
• Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.

  2012cited by this paper
• Tumour evolution inferred by single-cell sequencing

  2011cited by this paper
• Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma

  2011cited by this paper
• Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View

  2011cited by this paper
• Incidence of adenocarcinoma among patients with Barrett's esophagus.

  2011cited by this paper
• Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

  2011cited by this paper
• Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study

  2010cited by this paper
• Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

  2010cited by this paper
• Overdiagnosis in cancer.

  2010cited by this paper
• Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis

  2010cited by this paper
• Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

  2010influential reference
• The cancer genome

  2009cited by this paper
• Barrett's Esophagus and esophageal adenocarcinoma.

  2009cited by this paper
• Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays.

  2008cited by this paper
• Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression

  2008cited by this paper
• NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma

  2007cited by this paper
• Mucosal Defense in Barrett's Esophagus

  2007cited by this paper
• Epidemiology and pathogenesis of esophageal cancer.

  2007influential reference
• Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

  2006cited by this paper
• Genetic clonal diversity predicts progression to esophageal adenocarcinoma

  2006cited by this paper
• Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables

  2001cited by this paper
• Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus

  2000cited by this paper
• Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets

  2000cited by this paper
• Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

  1998cited by this paper
• The lasso method for variable selection in the Cox model.

  1997cited by this paper
• Surrogate End Points in Clinical Trials: Are We Being Misled?

  1996cited by this paper
• Surrogate endpoints in clinical trials: definition and operational criteria.

  1989cited by this paper
• Asymptotic Distribution Theory and Efficiency Results for Case-Cohort Studies

  1988cited by this paper
• A case-cohort design for epidemiologic cohort studies and disease prevention trials

  1986cited by this paper

• Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer

  2026cites this paper
• The biology and therapeutic implications of heterogeneity in Barrett oesophagus and oesophageal adenocarcinoma

  2025cites this paper
• Diagnostic and Prognostic Biomarkers for Barrett's Esophagus.

  2025cites this paper
• Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics analysis of progression from Barrett’s Esophagus to adenocarcinoma

  2025cites this paper
• Current Concepts for Diagnosing Non-Dysplastic and Dysplastic Barrett's Esophagus.

  2025cites this paper
• Studying Progression from Chronic Injury to Esophageal Adenocarcinoma

  2024cites this paper
• Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic Therapy

  2024cites this paper
• Degree of crypt atypia correlates with progression to high‐grade dysplasia/adenocarcinoma in non‐dysplastic Barrett's oesophagus

  2023cites this paper
• Concerted epithelial and stromal changes during progression of Barrett’s Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysis

  2023cites this paper
• Surveillance in Barrett's Esophagus: Challenges, Progress and Possibilities.

  2023cites this paper
• Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics

  2022cites this paper
• Today’s Mistakes and Tomorrow’s Wisdom in Development and Use of Biomarkers for Barrett’s Esophagus

  2022cites this paper
• Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma

  2021cites this paper
• Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy

  2021cites this paper
• Evolution and progression of Barrett’s oesophagus to oesophageal cancer

  2021cites this paper
• Genomic instability signals offer diagnostic possibility in early cancer detection.

  2021cites this paper
• Recurring Translocations in Barrett’s Esophageal Adenocarcinoma

  2021cites this paper
• Somatic whole genome dynamics of precancer in Barrett’s esophagus reveals features associated with disease progression

  2021cites this paper
• Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

  2021cites this paper
• The SpaTemp cohort: 168 nondysplastic Barrett’s esophagus surveillance patients with and without progression to early neoplasia to evaluate the distribution of biomarkers over space and time

  2020cites this paper
• Risk stratification in Barrett's esophagus patients with diagnoses of indefinite for dysplasia: the definite silver bullet has not (yet) been found.

  2020cites this paper
• Genomic copy number predicts esophageal cancer years before transformation

  2020cites this paper
• Negative selection may cause grossly altered but broadly stable karyotypes in metastatic colorectal cancer

  2020cites this paper
• A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett’s esophagus patients after extended follow up; results from Dutch surveillance cohorts.

  2020cites this paper
• Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.

  2020cites this paper
• Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia

  2020cites this paper
• Artificial intelligence technique in detection of early esophageal cancer

  2020cites this paper
• Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues

  2020cites this paper
• Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists?

  2020cites this paper
• Genomic copy number predicts esophageal cancer years before transformation

  2020cites this paper
• Complex structural rearrangements are present in high-grade dysplastic Barrett’s oesophagus samples

  2019cites this paper
• Interactive decision support for esophageal adenocarcinoma screening and surveillance

  2019cites this paper
• AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health

  2018cites this paper
• Biomarkers for Barrett’s esophagus – a contemporary review

  2018cites this paper
• Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels

  2018cites this paper
• Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus

  2018cites this paper
• The metaplastic mosaic of Barrett’s oesophagus

  2018cites this paper
• Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.

  2018cites this paper
• Precancer Atlas to Drive Precision Prevention Trials.

  2017cites this paper
• Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective

  2017cites this paper
• Pathway Cross-Talk Analysis in Detecting Significant Pathways in Barrett’s Esophagus Patients

  2017cites this paper
• Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma

  2017cites this paper
• Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

  2017cites this paper
• Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract

  2016cites this paper
• Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.

  2016cites this paper
• Surrogate Markers: Lessons from the Next Gen?

  2016cites this paper
• Cranberry proanthocyanidins modulate reactive oxygen species in Barrett’s and esophageal adenocarcinoma cell lines

  2016cites this paper
• Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma

  2016influential citation
• Clinical Study of Ursodeoxycholic Acid in Barrett's Esophagus Patients

  2016cites this paper
• Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening

  2015cites this paper
• Genomic Diversity and the Microenvironment as Drivers of Progression in DCIS

  2015cites this paper
• Risk strati fi cation in Barrett ’ s esophagus patients with diagnoses of inde fi nite for dysplasia: the de fi nite silver bullet has not (yet) been found

  year unknowncites this paper